Skip to main content
Top

Journal of Endocrinological Investigation

Issue 2/2020

Content (15 Articles)

Immunohistochemical analysis of human orbital tissue in Graves’ orbitopathy

Y. P. Hai, A. C. H. Lee, L. Frommer, T. Diana, G. J. Kahaly

Insulinoma Short Review

The functioning side of the pancreas: a review on insulinomas

I. Maggio, V. Mollica, N. Brighi, G. Lamberti, L. Manuzzi, A. D. Ricci, D. Campana

Multinodular Goiter Original Article

Genetic interaction analysis of VEGF-A rs3025039 and VEGFR-2 rs2071559 identifies a genetic profile at higher risk to develop nodular goiter

A. Molinaro, P. Orlandi, F. Niccolai, P. Agretti, G. De Marco, E. Ferrarini, C. Di Cosmo, P. Vitti, P. Piaggi, T. Di Desidero, G. Bocci, M. Tonacchera

Hyperthyroidism Original Article

The clinical phenotype of Graves’ disease occurring as an isolated condition or in association with other autoimmune diseases

M. Rotondi, C. Virili, S. Pinto, F. Coperchini, L. Croce, N. Brusca, M. Centanni, L. Chiovato

Acromegaly Original Article

Exon 3-deleted growth hormone receptor isoform is not related to worse bone mineral density or microarchitecture or to increased fracture risk in acromegaly

J. Pontes, M. Madeira, C. H. A. Lima, L. L. Ogino, F. de Paula Paranhos Neto, L. M. C. de Mendonça, M. L. F. Farias, L. Kasuki, M. R. Gadelha

Original Article

Clinical and genetic analysis of idiopathic normophosphatemic tumoral calcinosis in 19 patients

Q.-Y. Zuo, X. Cao, B.-Y. Liu, D. Yan, Z. Xin, X.-H. Niu, C. Li, W. Deng, Z.-Y. Dong, J.-K. Yang

Hypercholesterolemia Original Article

Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational study

V. Gasco, L. Roncoroni, M. Zavattaro, C. Bona, A. Berton, E. Ghigo, M. Maccario, S. Grottoli

Alemtuzumab Original Article

Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis

L. Scappaticcio, M. Castellana, C. Virili, G. Bellastella, M. Centanni, S. Cannavò, A. Campennì, R. M. Ruggeri, L. Giovanella, P. Trimboli

Hyperparathyroidism Original Article

Whole exome sequencing in familial isolated primary hyperparathyroidism

F. Cetani, E. Pardi, P. Aretini, F. Saponaro, S. Borsari, L. Mazoni, M. Apicella, P. Civita, M. La Ferla, M. A. Caligo, F. Lessi, C. M. Mazzanti, L. Torregossa, A. Oppo, C. Marcocci

Hypercalcemia Rapid Communication

Dysregulated mitogen-activated protein kinase pathway mediated cell cycle disruption in sporadic parathyroid tumors

A. K. Arya, P. Singh, U. N. Saikia, N. Sachdeva, D. Dahiya, A. Behera, S. D. Rao, S. K. Bhadada

Thyrotoxicosis Letter to the Editor

A complete flaccid quadriparesis as early presentation of Graves’ disease

L. Di Filippo, E. Bosi, S. Martinenghi

Propylthiouracil Consensus Statement

Treatment of Graves’ hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy

M. Tonacchera, L. Chiovato, L. Bartalena, A. F. Cavaliere, P. Vitti

Endo&Art

Could Amedeo Modigliani have painted a thyroid swelling?

R. Accorona, A. Iandelli, L. Calabrese

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine